ACR24 - RHEUMATOID ARTHRITIS

Save

A New ACR Cancer Survival in RA "Changing Mindsets about Methotrexate Side Effects" Control RA, Build Stronger Bones Cumulative Steroid Use and Cardiovascular Events Disease Activity in RA-ILD Do TNFis and JAKis Prevent Cancer!? Estimating Inflammation, Damage and Patient Distress Finding the Right Combination Therapy in RA Implantable Vagus Nerve Stimulator for RA Is Frequent Lab Monitoring Necessary? Long Term Follow up from APIPPRA Metabolic D

ACR24 - IL - 17

Save

A New ACR Anti IL-17 on Entheseal Biopsy in PsA axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure Best Things I Saw Today in PsA Cycling vs Switching after TNFi Failure in axSpA Improvements in Pain and Fatigue in Bimekizumab Long-term Safety Profile of Bimekizumab in axSpA and PsA Sonelokimab in PsA: Phase 2 Data Treating SpA

ACR24 - JAK TYK2

Save

A New ACR Best Things I Saw Today in PsA Do TNFis and JAKis Prevent Cancer!? Hold or continue JAKi and IL-17 when receiving COVID boosters? JAK-pot! How fast do DMARDs work? JAKi Studies at ACR Poly-treatment of Polymyalgia Rheumatica? RA Roundup: Is LDA Inappropriate?

ACR24 - LUPUS

Save

A Fibroblast Renaissance A New ACR A useful urinary biomarker for lupus nephritis ANA+ and no Autoimmune Disease? Check the liver CAR-T Therapy and Lupus Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis Evaluating ANA Patterns and Titers with AI Neuropsychiatric Lupus: The Forgotten Symptoms The 2024 ACR Guidelines for Lupus Nephritis Vaccine Responses:The DMARD Counts What is MCTD? The Great Debate

ACR24 - SPONDYLOARTHRITIS

Save

A New ACR Assessing ASAS Criteria: CLASSIC Study Results Assessment and management of axSpA Assessment of axSpA Carotid Doppler Ultrasound Screening in Axial SpA Cycling vs Switching after TNFi Failure in axSpA Defining Difficult to Manage axSpA Difficult to manage AxSpA DISH in SpA Gender Differences in AxSpA Highlights in axSpA Hot Topics in axSpA Long-term Safety Profile of Bimekizumab in axSpA and PsA Machine Learning for Predicting Flares in

ACR24 - PSORIATIC ARTHRITIS

Save

A New ACR Apremilast Benefits and Risks in PsA Best Things I Saw Today in PsA Bimekizumab in PsA Showed Sustained Reductions in Disease Impact Biologic Monotherapy vs Combination with cDMARDs in PsA Do TNFis and JAKis Prevent Cancer!? Improvements in Pain and Fatigue in Bimekizumab Long-term Safety Profile of Bimekizumab in axSpA and PsA Potential Impact of Weight Loss Drugs in Rheumatic Diseases Proposed ACR Guidance for Use of MSUS in Psoriatic

ACR24 - Day4c

Save

Is Frequent Lab Monitoring Necessary?:Dr. Bella Mehta The Case for JAKi in PMR:Dr. David Liew Treatment Strategies in RA:Dr. Victoria Konzett What's New in Relapsing Polychondritis?:Dr. Bella Mehta Worried about CV Risk and JAKi? What about the Steroids?:Dr. David Liew

ACR24 - Day4b

Save

ANCA Vasculitis "Eye": Can rituximab help?:Dr. Janet Pope Apremilast in PsA: Results from Mosaic Trial:Dr. Guillermo Valenzuela Implantable Vagus Nerve Stimulator for RA:Dr. Guillermo Valenzuela Treat-to-Target Improves Fertility in Women with RA:Dr. Richard Conway

RheumNow Day 4 Recap ACR Convergence 2024 Highlights

Save

Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

ACR24 - Day4a

Save

ACR 24: What I learned in Sjogren's, Takayasu's and CAR-T:Dr. Janet Pope Anti IL-17 on Entheseal Biopsy in PsA:Dr. Eric Dein axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure:Dr. Brian Jaros Can We Make Clinical Trials Better?:Dr. Janet Pope Cumulative Steroid Use and Cardiovascular Events:Dr. Mrinalini Dey IL 6 Inhibitors, Frailty and Polymyalgia Rheumatica:Drs.

RheumNow Day 3 Recap ACR Convergence 2024 Highlights

Save

Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

ACR24 -Day3b

Save

Best Things I Saw Today in PsA:Dr. Catherine Bakewell Do TNFis and JAKis Prevent Cancer!?:Dr. Richard Conway Efficacy and Safety of Nipocalimab for Sjogren's Syndrome:Dr. Mike Putman Evaluating ANA Patterns and Titers with AI:Dr. Bella Mehta Improvements in Pain and Fatigue in Bimekizumab:Dr. Philip Mease Long Term Follow up from APIPPRA:Dr. Antoni Chan talks with Dr. Andrew Cope Race Neutral PFTs in Scleroderma Improves Equity:Dr.

ACR24 - Day3a

Save

Control RA, Build Stronger Bones:Dr. Jiha Lee talks with Dr. Rachel Elam Hold or continue JAKi and IL-17 when receiving COVID boosters?:Dr. Bella Mehta Long-term Safety Profile of Bimekizumab in axSpA and PsA:Dr. Philip Mease Navigating Rheumatology Care in Humanitarian Crisis Settings:Dr. Antoni Chan talks with Dr. Martha Dhzhus RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?:Dr.

ACR24 - Day2d

Save

Assessment of axSpA:Dr. Antoni Chan Defining Difficult to Manage axSpA:Dr. Lihi DISH in SpA:Dr. Sheila Reyes Generative AI in Rheumatology: The Good, The Bad, The Ugly:Dr. Akhil Sood Native Americans with RA Die Young:Dr. Eric Dein Precision Immunotherapy in Axial SpA:Dr. Marina Magrey When, What and How Long to Treat GCA & PMR:Dr. Janet Pope

ACR24 - Day2c

Save

A Fibroblast Renaissance:Dr. Andrea Fava A useful urinary biomarker for lupus nephritis:Dr. Andrea Fava ACR Advocacy Update:Dr. Eric Dein talks with Dr. Christina Downey, ACR Government Affairs Committee, and Dr. Kaitlyn Brittan, RheumPAC Carotid Doppler Ultrasound Screening in Axial SpA:Dr. Trish Harkins discussed with Dr. Barry O'Shea Enhanced Detection of Myocarditis in Idiopathic Inflammatory Myopathies:Dr.